Nuvation Bio reports Q3 EPS of USD -0.12
Nuvation Bio reported Q3 income from operations of USD -42.21 million.
Related stories
Sensex Holds Firm at 8-Month High
India’s BSE Sensex rose about 1.6% to 82,392 on Wednesday, extending its winning streak to nine consecutive sessions and holding at its highest level since late February, as softer
H impact | EARNINGS | Nov 11, 2026, 04:50 AM UTC
Alcon AG earnings above expectations at 0.91 CHF
Alcon AG (ALC) released earnings per share at 0.91 CHF, compared to market expectations of 0.89 CHF.
H impact | EARNINGS | Nov 11, 2026, 04:29 AM UTC
Softbank earnings below expectations at -196.55 JPY
Softbank (9984) released earnings per share at -196.55 JPY, compared to market expectations of 21.24 JPY.
H impact | EARNINGS | Nov 11, 2026, 04:29 AM UTC
Copper Rebounds on Tightening Supply in China
Copper futures climbed toward $6.30 per pound on Wednesday, recovering from four-month lows amid tightening physical supply in China, the world’s largest copper consumer. Import pr
H impact | EARNINGS | Nov 11, 2026, 04:29 AM UTC
Honda Motor earnings below expectations at 16.91 JPY
Honda Motor (7267) released earnings per share at 16.91 JPY, compared to market expectations of 17.53 JPY.
H impact | EARNINGS | Nov 11, 2026, 04:29 AM UTC
Fortuna Mining Forecasts 2026 AISC of $1,830–$1,975 per Gold-Equivalent Ounce
Fortuna Mining forecasts 2026 all-in sustaining costs of $1,830–$1,975 per gold-equivalent ounce.
M impact | EARNINGS | Nov 11, 2026, 04:20 AM UTC